Experimental drug inhibits cell signaling pathway and slows ovarian cancer growth

An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found.

Read the whole article on Physorg

More from Physorg